Combined Prognostic Factors Clarify Colorectal Cancer Risk

Dr David Kerr on how combining ploidy and stroma-tumor fraction can guide treatment decisions in patients with stage II disease.

Source: Medscape Oncology - March 12, 2018 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts